Zhende Medical: The US tariff policy has no impact on the company yet, and the Mexican production base may be completed next year | Direct hit on earnings conference
①Zhende Medical's chairman Lu Jianguo introduced at the earnings conference that the construction of the new production base in Mexico is expected to be completed next year; ② Zhende Medical explained the company's Q3 operation situation, with further decrease in revenue from isolation protective equipment.
Buffett Trims Apple, Bank of America; Picks Two New Favorites
yabao pharmaceutical group's two children's medicines revenue increased year-on-year, hydrochloride betahistine injection has not stopped the decline in revenue|direct hit earnings conference
yabao pharmaceutical group stated at the earnings conference that in the first three quarters of this year, the company's pediatric products revenue increased year-on-year. The company's secretary stated that while the revenue of levocetirizine hydrochloride injection decreased, the sales volume increased, and predicted that the 'income decline in the category will continue to narrow within the year'. yabao pharmaceutical group also provided explanations on the company's research pipeline progress, share buybacks, and other situations.
The trend of social security fund holdings has been exposed: in the third quarter, 123 new stocks were added to the top ten list of public shareholders, with guangxi energy and zhongman petroleum and natural gas group corp.,ltd. adding a large number of i
①With the completion of the disclosure of the third quarter report, the holding positions trends of social security funds in the third quarter are also revealed; ②The list of the top ten circulating shareholders of 123 new stocks; ③Attached is the list of A-share institutions with the highest number of new holdings by social security funds in the third quarter (see table).
china kings resources group Q3 net profit decreased by more than 30%, rare interim report distributing dividends|interpretations
①In the peak season encountered a downturn, the company's Q3 net income attributable to the mother is less than 83 million yuan; ②The net profit growth rate of the company has declined quarter by quarter, far from the institutional forecast target; ③The main reasons for the decline in the prosperity of mines shut down and new products such as lithium carbonate; ④The company is optimistic about Q4 expectations, expecting sales volume and prices to increase month-on-month.
Overseas new production capacity entering the release period. Jiangsu General Science Technology's Q3 revenue increased by more than 30% year-on-year | Financial interpretations
①Overseas new production capacity is being put into operation one after another, with full orders for semi-steel tires and jiangsu general science technology's revenue scale continuing to expand; ②Company officials stated that in Q3 of this year, the company faced issues such as rising raw material prices, increased marine transportation costs, and high cost amortization. As we enter the fourth quarter, cost pressures have already eased.